Literature DB >> 23063381

The role of plasma granulocyte colony stimulating factor and bone marrow dysfunction after severe trauma.

Kristin M Cook1, Ziad C Sifri, Gregg M Baranski, Alicia M Mohr, David H Livingston.   

Abstract

BACKGROUND: Bone marrow dysfunction is common in severely injured trauma patients, with release of hematopoietic progenitor cells (HPC) into the peripheral blood. Granulocyte colony stimulating factor (G-CSF) is a potent stimulator of HPC mobilization. We hypothesized that plasma G-CSF levels are elevated after trauma and correlate with postinjury anemia and infection. STUDY
DESIGN: Blood from 83 severely injured patients was collected at several time points for determination of G-CSF levels and HPC mobilization and compared with that from healthy volunteers. Data were categorized by age, sex, Injury Severity Score (ISS), and whether the patient was in shock. Hemoglobin and transfusion requirements and hospital-acquired infection data were recorded. Data are expressed as mean ± SEM.
RESULTS: After trauma, there is a 50-fold increase in plasma levels of G-CSF in trauma patients compared with controls (1,640.4 ± 304.3 pg/mL vs 33.0 ± 6.8 pg/mL, p < 0.001). Patients who presented in shock had 5-times higher G-CSF levels than nonshock trauma patients and a 75-fold increase compared with controls (2,528.7 ± 536.4 pg/mL vs 728.0 ± 191.0 pg/mL vs 33.0 ± 6.8 pg/mL, p < 0.001). Age, sex, and ISS had no effect on G-CSF levels. Mobilization of HPC was sustained for up to 10 days after injury and involved multiple cells types. Higher G-CSF levels were also associated with lower hemoglobin levels and greater transfusion requirements 3 weeks after injury and a higher incidence of hospital-acquired pneumonia and bacteremia.
CONCLUSIONS: Plasma G-CSF is markedly elevated after injury and is greater in patients who present in shock. The rise in G-CSF was also associated with prolonged mobilization of HPC. Elevation of G-CSF in humans after severe trauma may play a significant role in the development of post-traumatic bone marrow dysfunction, anemia, and infection.
Copyright © 2013 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23063381      PMCID: PMC3541679          DOI: 10.1016/j.jamcollsurg.2012.08.028

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  21 in total

Review 1.  Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor.

Authors:  John Thomas; Fulu Liu; Daniel C Link
Journal:  Curr Opin Hematol       Date:  2002-05       Impact factor: 3.284

2.  Inadequate granulopoiesis after major torso trauma: a hematopoietic regulatory paradox.

Authors:  F A Moore; V M Peterson; E E Moore; C Rundus; R Poggetti
Journal:  Surgery       Date:  1990-10       Impact factor: 3.982

3.  Granulocyte colony-stimulating factor (G-CSF) production in hemorrhagic shock requires both the ischemic and resuscitation phase.

Authors:  C Hierholzer; E Kelly; T R Billiar; D J Tweardy
Journal:  Arch Orthop Trauma Surg       Date:  1997       Impact factor: 3.067

4.  Differential effects of recombinant human colony stimulating factor (rh G-CSF) on stem cells in marrow, spleen and peripheral blood in mice.

Authors:  B Bungart; M Loeffler; H Goris; B Dontje; V Diehl; W Nijhof
Journal:  Br J Haematol       Date:  1990-10       Impact factor: 6.998

5.  Blood transfusion, independent of shock severity, is associated with worse outcome in trauma.

Authors:  Debra L Malone; James Dunne; J Kathleen Tracy; A Tyler Putnam; Thomas M Scalea; Lena M Napolitano
Journal:  J Trauma       Date:  2003-05

6.  Bone marrow failure following severe injury in humans.

Authors:  David H Livingston; Devashish Anjaria; Jonathan Wu; Carl J Hauser; Victor Chang; Edwin A Deitch; Pranela Rameshwar
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

7.  Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia.

Authors:  G de Haan; M Loeffler; W Nijhof
Journal:  Exp Hematol       Date:  1992-06       Impact factor: 3.084

8.  Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization.

Authors:  Thalia Papayannopoulou
Journal:  Blood       Date:  2003-11-06       Impact factor: 22.113

9.  Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis.

Authors:  H Tanaka; K Ishikawa; M Nishino; T Shimazu; T Yoshioka
Journal:  J Trauma       Date:  1996-05

10.  Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor.

Authors:  G E Tjønnfjord; R Steen; S A Evensen; E Thorsby; T Egeland
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

View more
  22 in total

1.  Clonidine reduces norepinephrine and improves bone marrow function in a rodent model of lung contusion, hemorrhagic shock, and chronic stress.

Authors:  Ines G Alamo; Kolenkode B Kannan; Harry Ramos; Tyler J Loftus; Philip A Efron; Alicia M Mohr
Journal:  Surgery       Date:  2016-10-11       Impact factor: 3.982

2.  Systemic Regulation of Bone Marrow Stromal Cytokines After Severe Trauma.

Authors:  Elizabeth S Miller; Tyler J Loftus; Kolenkode B Kannan; Jessica M Plazas; Philip A Efron; Alicia M Mohr
Journal:  J Surg Res       Date:  2019-06-14       Impact factor: 2.192

Review 3.  Impaired hematopoietic progenitor cells in trauma hemorrhagic shock.

Authors:  Manoj Kumar; Sanjeev Bhoi
Journal:  J Clin Orthop Trauma       Date:  2016-06-22

4.  Mesenchymal stem cells reverse trauma and hemorrhagic shock-induced bone marrow dysfunction.

Authors:  Amy V Gore; Letitia E Bible; David H Livingston; Alicia M Mohr; Ziad C Sifri
Journal:  J Surg Res       Date:  2015-06-16       Impact factor: 2.192

5.  Thermal injury of the skin induces G-CSF-dependent attenuation of EPO-mediated STAT signaling and erythroid differentiation arrest in mice.

Authors:  John G Noel; Benjamin J Ramser; Jose A Cancelas; Francis X McCormack; Jason C Gardner
Journal:  Exp Hematol       Date:  2017-09-01       Impact factor: 3.084

6.  The effects of selective beta-adrenergic blockade on bone marrow dysfunction following severe trauma and chronic stress.

Authors:  Elizabeth S Miller; Camille G Apple; Kolenkode B Kannan; Zackary M Funk; Philip A Efron; Alicia M Mohr
Journal:  Am J Surg       Date:  2020-07-25       Impact factor: 2.565

7.  Predictive value of cytokines for developing complications after polytrauma.

Authors:  Anne-Britt E Dekker; Pieta Krijnen; Inger B Schipper
Journal:  World J Crit Care Med       Date:  2016-08-04

8.  G-CSF drives a posttraumatic immune program that protects the host from infection.

Authors:  Jason C Gardner; John G Noel; Nikolaos M Nikolaidis; Rebekah Karns; Bruce J Aronow; Cora K Ogle; Francis X McCormack
Journal:  J Immunol       Date:  2014-01-27       Impact factor: 5.422

9.  Early propranolol administration to severely injured patients can improve bone marrow dysfunction.

Authors:  Letitia E Bible; Latha V Pasupuleti; Walter D Alzate; Amy V Gore; Kim J Song; Ziad C Sifri; David H Livingston; Alicia M Mohr
Journal:  J Trauma Acute Care Surg       Date:  2014-07       Impact factor: 3.313

10.  Do all β-blockers attenuate the excess hematopoietic progenitor cell mobilization from the bone marrow following trauma/hemorrhagic shock?

Authors:  Latha V Pasupuleti; Kristin M Cook; Ziad C Sifri; Walter D Alzate; David H Livingston; Alicia M Mohr
Journal:  J Trauma Acute Care Surg       Date:  2014-04       Impact factor: 3.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.